Share Information
| Listing | LSE |
| Ticker | IDHC |
| LSE Listing | May 2015 |
| ISIN Code | EGS99021C015 |
| Sector | Health Care & Pharmaceuticals |
| Par Value / Share | USD 0.25 |
| Number of Listed Shares | 581,326,272 |
| Issued Capital | USD 145,331,568 |
| Paid-In Capital | USD 145,331,568 |
Shareholding Structure
| % | |
| Free Float 50.38% | 50.38 |
| Actis* IDH B.V. 21.67% | 21.67 |
| Hena Holdings Ltd 27.94% | 27.94 |
*The Board has been informed by Actis, which through funds under its management is the owner of shares representing 21.67% of the Company (the "Actis Shareholding"), that Actis has entered into a conditional agreement to dispose, by way of an indirect share sale, of the entire Actis Shareholding to a special purpose vehicle controlled by funds managed by Elliott Investment Management L.P. (the "Transaction"). The Transaction is conditional on typical closing conditions, including the receipt of any required regulatory clearance.
LSE SHARE PRICE
0.62USD
Last Close Price
0.83USD
52-Week High
0.31USD
52-Week Low
372.00USD
Market Cap (USD mn)
Historical Share Price Chart
* On 23 December 2020, IDH held an Extraordinary General Meeting where shareholders decided to undertake a subdivision of the Company's issued share capital, pursuant to which each Share was subdivided into four Shares. The subdivision was intended to bring the trading price of the Shares more in line with typical trading prices on the EGX in preparation for the Company's dual listing.